Valuation: Bayer AG

Market Cap 47.85B 55.25B 45.25B 40.97B 76.89B 5,299B 77.47B 540B 208B 2,687B 208B 203B 8,570B P/E 2026 *
22x
P/E 2027 * 15.9x
Enterprise Value 77.81B 89.82B 73.57B 66.61B 125B 8,616B 126B 878B 338B 4,369B 337B 330B 13,933B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.15%
1 week+4.32%
Current month+4.32%
1 month+5.22%
3 months+43.44%
6 months+32.29%
Current year+42.67%
1 week 210.5
Extreme 210.5
220
1 month 206.7
Extreme 206.7
220
3 years 78.97
Extreme 78.97
231.65
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+4.51%+85.38%-5.20% 55.25B
-0.19%+1.09%+51.85%+97.36% 1,013B
+0.33%-0.71%+50.62%+65.50% 644B
+0.49%+5.73%+20.88%+72.92% 465B
-0.22%+2.88%+38.48%+37.98% 352B
-0.07%+1.82%+16.57%+23.39% 264B
-0.31%+2.02%+6.15%+10.75% 253B
-1.53%-4.46%+36.90%+44.08% 203B
-1.60%-5.51%-22.30%-58.60% 188B
+0.49%-0.23%+30.00%+93.34% 181B
Average -0.08%-1.08%+31.45%+38.15% 395.97B
Weighted average by Cap. +0.41%+0.01%+35.29%+58.44%

Financials

2026 *2027 *
Net sales 45.78B 52.85B 43.29B 39.19B 73.55B 5,069B 74.1B 517B 199B 2,570B 199B 194B 8,197B 46.99B 54.24B 44.43B 40.22B 75.49B 5,203B 76.06B 530B 204B 2,638B 204B 199B 8,414B
Net income 2.14B 2.47B 2.03B 1.83B 3.44B 237B 3.47B 24.17B 9.3B 120B 9.29B 9.08B 384B 2.94B 3.39B 2.78B 2.51B 4.72B 325B 4.76B 33.15B 12.75B 165B 12.74B 12.46B 526B
Net Debt 29.95B 34.58B 28.32B 25.64B 48.12B 3,317B 48.49B 338B 130B 1,682B 130B 127B 5,364B 26.82B 30.97B 25.36B 22.96B 43.1B 2,970B 43.42B 303B 116B 1,506B 116B 114B 4,803B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
26-09-15 PLN 219.60 -0.18%
26-09-14 PLN 220.00 0.00%
26-09-11 PLN 220.00 +3.58%
26-09-10 PLN 212.40 +0.90%
26-09-09 PLN 210.50 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.71EUR
Average target price
58.22EUR
Spread / Average Target
+19.53%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!